Exact Mass: 302.1756094

Exact Mass Matches: 302.1756094

Found 125 metabolites which its exact mass value is equals to given mass value 302.1756094, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Glycerol tributanoate

1,3-bis(butanoyloxy)propan-2-yl butanoate

C15H26O6 (302.1729296)


Flavouring agent. Glycerol tributanoate is found in many foods, some of which are durian, canola, conch, and italian sweet red pepper. C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer Glycerol tributanoate is a flavouring agent

   

Arginylglutamine

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C11H22N6O4 (302.1702452)


Arginylglutamine is a dipeptide composed of arginine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutaminylarginine

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-5-carbamimidamidopentanoate

C11H22N6O4 (302.1702452)


Glutaminylarginine is a dipeptide composed of glutamine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Arginyl-Gamma-glutamate

2-Amino-4-[(2-amino-5-carbamimidamidopentanoyl)-C-hydroxycarbonimidoyl]butanoate

C11H22N6O4 (302.1702452)


Arginyl-Gamma-glutamate is a dipeptide composed of arginine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

DL-Valine-4-antipyrineamide

2-Amino-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-methylbutanimidate

C16H22N4O2 (302.1742672)


   

1,1,1-Tri(butyryloxy)propane

1,1-Bis(butanoyloxy)propyl butanoic acid

C15H26O6 (302.1729296)


   

tributyrylglycerol

5-butanoyl-5,6-dihydroxy-6-(hydroxymethyl)decane-4,7-dione

C15H26O6 (302.1729296)


   
   
   
   

2,4-Bis(1-phenylethyl)phenol

2,4-Bis(1-phenylethyl)phenol

C22H22O (302.1670562)


   
   
   

2,6-bis(1-phenylethyl)phenol

2,6-bis(1-phenylethyl)phenol

C22H22O (302.1670562)


   

leptoclinidamide trifluoroacetic acid salt

leptoclinidamide trifluoroacetic acid salt

C16H22N4O2 (302.1742672)


   

deschloro 12-epi-fischerindole I nitrile

deschloro 12-epi-fischerindole I nitrile

C21H22N2 (302.1782892)


   

geranil-3(10)-en-9-carboxyl-beta-arabinopyranoside|geranilenyl carboxy arabinoside

geranil-3(10)-en-9-carboxyl-beta-arabinopyranoside|geranilenyl carboxy arabinoside

C15H26O6 (302.1729296)


   

cis,cis-4,5-didehydro-siphonochalynol|Dehydrosiphonochalynol|docosa-4c,19c-diene-2,9,11,13,21-pentayn-1-ol

cis,cis-4,5-didehydro-siphonochalynol|Dehydrosiphonochalynol|docosa-4c,19c-diene-2,9,11,13,21-pentayn-1-ol

C22H22O (302.1670562)


   

pyxidatol A|rel-(1R,2R,2aS,3S,4R,4aS,7aR,7bR)-decahydro-3-(hydroxymethyl)-6,6,7b-trimethyl-2aH-cyclobut[e]indene-1,2,2a,3,4-pentol

pyxidatol A|rel-(1R,2R,2aS,3S,4R,4aS,7aR,7bR)-decahydro-3-(hydroxymethyl)-6,6,7b-trimethyl-2aH-cyclobut[e]indene-1,2,2a,3,4-pentol

C15H26O6 (302.1729296)


   

4-Dimethylamino-tritylamin|4-dimethylamino-tritylamine|alpha-Amino-4-dimethylamino-triphenylmethan

4-Dimethylamino-tritylamin|4-dimethylamino-tritylamine|alpha-Amino-4-dimethylamino-triphenylmethan

C21H22N2 (302.1782892)


   
   
   
   
   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

NCGC00169348-03!(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

C16H22N4O2 (302.1742672)


   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based on: CCMSLIB00000848599]

NCGC00169348-03!(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based on: CCMSLIB00000848599]

C16H22N4O2 (302.1742672)


   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based: Match]

NCGC00169348-03!(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione [IIN-based: Match]

C16H22N4O2 (302.1742672)


   

Tributyrin (C4:0)

Tributyrin (C4:0)

C15H26O6 (302.1729296)


   

butyrin

Glyceryl tributyrate

C15H26O6 (302.1729296)


A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by butyric acid. C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer

   
   
   
   
   
   
   

Arg-GLN

2-(2-amino-4-carbamoylbutanamido)-5-carbamimidamidopentanoic acid

C11H22N6O4 (302.1702452)


A dipeptide formed from L-arginyl and L-glutamine residues.

   

Arg-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-5-carbamimidamidopentanoic acid

C11H22N6O4 (302.1702452)


   

GLN-Arg

2-(2-amino-5-carbamimidamidopentanamido)-4-carbamoylbutanoic acid

C11H22N6O4 (302.1702452)


   

GGlu-Arg

2-(2-amino-5-carbamimidamidopentanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

C11H22N6O4 (302.1702452)


   

FOH 22:12

(4Z,19Z)-docosa-4,19-diene-2,9,11,13,21-pentayne-1-ol

C22H22O (302.1670562)


   

ascr#3

8R-(3,6-dideoxy-alpha-L-arabino-hexopyranosyloxy)-2E-nonenoic acid

C15H26O6 (302.1729296)


An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,8R)-8-hydroxynon-2-enoic acid with ascarylopyranose (the alpha anomer). It is a major component of the dauer pheromone, used by the nematode Caenorhabditis elegans as a population-density signal to promote entry into an alternate larval stage, the nonfeeding and highly persistent dauer diapause, and also synergises with ascr#2, ascr#4, and ascr#8 in male attraction.

   

oscr#3

9-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-nonenoic acid

C15H26O6 (302.1729296)


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-9-hydroxynon-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

tert-butyl 4-(1H-indazol-5-yl)piperazine-1-carboxylate

tert-butyl 4-(1H-indazol-5-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1742672)


   

(3-Cyano-3,4,5,6-tetrahydro-2H-[1,2]bipyridinyl-4-yl)-carbamic acid tert-butyl ester

(3-Cyano-3,4,5,6-tetrahydro-2H-[1,2]bipyridinyl-4-yl)-carbamic acid tert-butyl ester

C16H22N4O2 (302.1742672)


   
   

2-({2,2-Bis[(oxiran-2-ylmethoxy)methyl]butoxy}methyl)oxirane

1-(2,3-epoxypropoxy)-2,2-bis[(2,3-epoxypropoxy)methyl]butane

C15H26O6 (302.1729296)


   

TERT-BUTYL 2-((4R,6S)-6-(ACETOXYMETHYL)-2,2-DIMETHYL-1,3-DIOXAN-4-YL)ACETATE

TERT-BUTYL 2-((4R,6S)-6-(ACETOXYMETHYL)-2,2-DIMETHYL-1,3-DIOXAN-4-YL)ACETATE

C15H26O6 (302.1729296)


   

3-(1-benzyl-1,2,3,6-tetrahydro-pyridin-4-yl)-2-methyl-1h-indole

3-(1-benzyl-1,2,3,6-tetrahydro-pyridin-4-yl)-2-methyl-1h-indole

C21H22N2 (302.1782892)


   

6-AMINO-3-AZETIDIN-1-YLMETHYL-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

6-AMINO-3-AZETIDIN-1-YLMETHYL-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C16H22N4O2 (302.1742672)


   
   

tert-Butyl 4-(1H-pyrrolo[3,2-b]pyridin-6-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-pyrrolo[3,2-b]pyridin-6-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1742672)


   

pyrrolidin-1-yl-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]methanone

pyrrolidin-1-yl-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]methanone

C16H23BN2O3 (302.1801638)


   

Benzenemethanol,4-methyl-a,a-bis(4-methylphenyl)-

Benzenemethanol,4-methyl-a,a-bis(4-methylphenyl)-

C22H22O (302.1670562)


   
   

ethyl 2-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]acetate

ethyl 2-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]acetate

C16H22N4O2 (302.1742672)


   

(4R-Cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-aceticacid,1,1-dimethylethylester

(4R-Cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-aceticacid,1,1-dimethylethylester

C15H26O6 (302.1729296)


   

1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXALDEHYDE, 1-[TRIS(1-METHYLETHYL)SILYL]-

1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXALDEHYDE, 1-[TRIS(1-METHYLETHYL)SILYL]-

C17H26N2OSi (302.1814306)


   

1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 1-[TRIS(1-METHYLETHYL)SILYL]-

1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 1-[TRIS(1-METHYLETHYL)SILYL]-

C17H26N2OSi (302.1814306)


   

1H-Pyrrolo[2,3-b]pyridine-3-carboxaldehyde, 1-[tris(1-methylethyl)silyl]-

1H-Pyrrolo[2,3-b]pyridine-3-carboxaldehyde, 1-[tris(1-methylethyl)silyl]-

C17H26N2OSi (302.1814306)


   

TERT-BUTYL 4-(IMIDAZO[1,2-A]PYRIDIN-5-YL)PIPERAZINE-1-CARBOXYLATE

TERT-BUTYL 4-(IMIDAZO[1,2-A]PYRIDIN-5-YL)PIPERAZINE-1-CARBOXYLATE

C16H22N4O2 (302.1742672)


   

tert-Butyl 4-(1H-pyrrolo[2,3-b]pyridin-4-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-pyrrolo[2,3-b]pyridin-4-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1742672)


   

Tandamine

Tandamine

C18H26N2S (302.18165960000005)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

1-Cyclopropyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea

1-Cyclopropyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea

C16H23BN2O3 (302.1801638)


   

1,2:3,4:5,6-tri-o-isopropylidene-d-mannitol

1,2:3,4:5,6-tri-o-isopropylidene-d-mannitol

C15H26O6 (302.1729296)


   

tert-butyl 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)piperidine-1-carboxylate

tert-butyl 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)piperidine-1-carboxylate

C16H22N4O2 (302.1742672)


   

tert-Butyl 4-(1H-indazol-3-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-indazol-3-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1742672)


   

tert-Butyl 4-(1H-indazol-6-yl)piperazine-1-carboxylate

tert-Butyl 4-(1H-indazol-6-yl)piperazine-1-carboxylate

C16H22N4O2 (302.1742672)


   

aluminum di(sec-butoxide)acetoacetic ester chelate

aluminum di(sec-butoxide)acetoacetic ester chelate

C14H27AlO5 (302.16738019999997)


   

1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine monoacetate

1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine monoacetate

C14H18N4.C2H4O2 (302.1742672)


   

2,2,2,2-[[(1S)-1-Methyl-1,2-ethanediyl]dinitrilo]tetrakisacetamide

2,2,2,2-[[(1S)-1-Methyl-1,2-ethanediyl]dinitrilo]tetrakisacetamide

C11H22N6O4 (302.1702452)


   

(E)-ethyl 3-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

(E)-ethyl 3-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

C17H23BO4 (302.1689308)


   

(E)-Ethyl 3-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

(E)-Ethyl 3-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylate

C17H23BO4 (302.1689308)


   

(2E)-9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]non-2-enoic acid

(2E)-9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]non-2-enoic acid

C15H26O6 (302.1729296)


   

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

(3Z)-3-[[5-(2-methylbut-3-en-2-yl)-1H-imidazol-4-yl]methylidene]-6-propan-2-ylpiperazine-2,5-dione

C16H22N4O2 (302.1742672)


   

(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic Acid

(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic Acid

C11H22N6O4 (302.1702452)


   
   

N-(N2-L-Alanyl-L-arginyl)glycine

N-(N2-L-Alanyl-L-arginyl)glycine

C11H22N6O4 (302.1702452)


   

N~2~,N~2~,N~4~,N~4~-Tetrakis(methoxymethyl)-1,3,5-triazine-2,4,6-triamine

N~2~,N~2~,N~4~,N~4~-Tetrakis(methoxymethyl)-1,3,5-triazine-2,4,6-triamine

C11H22N6O4 (302.1702452)


   

12-epi-fischerindole I

12-epi-fischerindole I

C21H22N2 (302.1782892)


   
   
   
   
   
   

6-De(cyclopropylamino)-6-(isobutylamino)abacavir

6-De(cyclopropylamino)-6-(isobutylamino)abacavir

C15H22N6O (302.1855002)


   

6-de(cyclopropylamino)-6-(S-sec-butylamino)abacavir

6-de(cyclopropylamino)-6-(S-sec-butylamino)abacavir

C15H22N6O (302.1855002)


   

2,6-DI(alpha-Methylbenzyl(5D))phenol

2,6-DI(alpha-Methylbenzyl(5D))phenol

C22H22O (302.1670562)


   
   
   

Arginyl-Gamma-glutamate

Arginyl-Gamma-glutamate

C11H22N6O4 (302.1702452)


   
   
   
   
   
   

RO-3

RO-3

C16H22N4O2 (302.1742672)


RO-3 is a potent, CNS-penetrant, and orally active P2X3 and P2X2/3 antagonist with pIC50s of 5.9 and 7.0 for human homomultimeric P2X3 and heteromultimeric P2X2/3 receptors, respectively. RO-3 shows selectivity for P2X3 and P2X2/3 over all other functional homomultimeric P2X receptors (IC50 >10?μM at P2X1,2,4,5,7)[1].

   

docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

C22H22O (302.1670562)


   

(6as,9s)-9-ethenyl-6,6,9-trimethyl-5h,6ah,7h,8h-indeno[2,1-b]indole-10-carbonitrile

(6as,9s)-9-ethenyl-6,6,9-trimethyl-5h,6ah,7h,8h-indeno[2,1-b]indole-10-carbonitrile

C21H22N2 (302.1782892)


   

9-ethenyl-6,6,9-trimethyl-5h,6ah,7h,8h-indeno[2,1-b]indole-10-carbonitrile

9-ethenyl-6,6,9-trimethyl-5h,6ah,7h,8h-indeno[2,1-b]indole-10-carbonitrile

C21H22N2 (302.1782892)


   

2-[(4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy]oxane-3,4,5-triol

2-[(4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy]oxane-3,4,5-triol

C15H26O6 (302.1729296)


   

acanthoine

NA

C16H22N4O2 (302.1742672)


{"Ingredient_id": "HBIN014343","Ingredient_name": "acanthoine","Alias": "NA","Ingredient_formula": "C16H22N4O2","Ingredient_Smile": "COC1=C(C=C(C=C1)C=CC(C=CCN=CN)N=CN)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "81","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

ethyl (2r,3s)-2-[(2z,3s)-n-hydroxy-2-(hydroxyimino)-3-methylpentanamido]-3-methylpentanoate

ethyl (2r,3s)-2-[(2z,3s)-n-hydroxy-2-(hydroxyimino)-3-methylpentanamido]-3-methylpentanoate

C14H26N2O5 (302.1841626)


   

2-[(1r)-1-phenylethyl]-6-[(1s)-1-phenylethyl]phenol

2-[(1r)-1-phenylethyl]-6-[(1s)-1-phenylethyl]phenol

C22H22O (302.1670562)


   

3-{[5-(n-hydroxy-3-methylbutanamido)pentyl]-c-hydroxycarbonimidoyl}propanoic acid

3-{[5-(n-hydroxy-3-methylbutanamido)pentyl]-c-hydroxycarbonimidoyl}propanoic acid

C14H26N2O5 (302.1841626)


   

3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

C15H26O6 (302.1729296)


   

(6z)-3-isopropyl-6-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-3h-pyrazine-2,5-diol

(6z)-3-isopropyl-6-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-3h-pyrazine-2,5-diol

C16H22N4O2 (302.1742672)


   

(2r,3r,4s,5s)-2-{[(2e,4s)-4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl]oxy}oxane-3,4,5-triol

(2r,3r,4s,5s)-2-{[(2e,4s)-4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl]oxy}oxane-3,4,5-triol

C15H26O6 (302.1729296)


   

2-[(1r)-1-phenylethyl]-4-[(1s)-1-phenylethyl]phenol

2-[(1r)-1-phenylethyl]-4-[(1s)-1-phenylethyl]phenol

C22H22O (302.1670562)


   

(2e)-4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

(2e)-4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

C15H26O6 (302.1729296)


   

3-amino-n-(2-{[2-(1h-indol-3-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl)propanimidic acid

3-amino-n-(2-{[2-(1h-indol-3-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl)propanimidic acid

C16H22N4O2 (302.1742672)


   

ethyl 2-[n-hydroxy-2-(hydroxyimino)-3-methylpentanamido]-3-methylpentanoate

ethyl 2-[n-hydroxy-2-(hydroxyimino)-3-methylpentanamido]-3-methylpentanoate

C14H26N2O5 (302.1841626)


   

(1r,2r,2as,3s,4r,4as,7ar,7br)-3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

(1r,2r,2as,3s,4r,4as,7ar,7br)-3-(hydroxymethyl)-6,6,7b-trimethyl-hexahydro-1h-cyclobuta[e]indene-1,2,2a,3,4-pentol

C15H26O6 (302.1729296)


   

7-methyl-1,3-bis(3-methylbut-2-en-1-yl)purine-2,6-dione

7-methyl-1,3-bis(3-methylbut-2-en-1-yl)purine-2,6-dione

C16H22N4O2 (302.1742672)


   

2,4-bis[(1r)-1-phenylethyl]phenol

2,4-bis[(1r)-1-phenylethyl]phenol

C22H22O (302.1670562)


   

ethyl (2s,3s)-2-[(2z,3s)-n-hydroxy-2-(hydroxyimino)-3-methylpentanamido]-3-methylpentanoate

ethyl (2s,3s)-2-[(2z,3s)-n-hydroxy-2-(hydroxyimino)-3-methylpentanamido]-3-methylpentanoate

C14H26N2O5 (302.1841626)


   

(1s,2s,5s,6s,7r,8s,9r,12r)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-2,5,7,8,12-pentol

(1s,2s,5s,6s,7r,8s,9r,12r)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-2,5,7,8,12-pentol

C15H26O6 (302.1729296)


   

5-hydroxy-6-isopropyl-3-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-1,6-dihydropyrazin-2-one

5-hydroxy-6-isopropyl-3-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-1,6-dihydropyrazin-2-one

C16H22N4O2 (302.1742672)


   

(4e,19e)-docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

(4e,19e)-docosa-4,19-dien-2,9,11,13,21-pentayn-1-ol

C22H22O (302.1670562)


   

4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

4,5,6-trihydroxy-6-[4-(hydroxymethyl)cyclohexyl]-2-methylhept-2-enoic acid

C15H26O6 (302.1729296)